Deletion of the short arm of chromosome 1 (1p), observed in about 40% of NBs, is strongly associated with a poor prognosis, and highly associated with MYCN amplification, which is itself a strong indicator of a poor outcome for advanced-type NB tumors [1]–[3], [37]. Here, MYCN is linked to neuroblastoma.